UPADACITINIB IS EFFICACIOUS IN REDUCING THE ALEXITHYMIC TRAIT IN ADULT PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: A PROSPECTIVE MULTICENTER REAL-LIFE STUDY